Retrosepctive Analysis of the efficacy and tolerability of pridinol in patients with muscle pain - an analysis of open-label real-world data provided by the German Pain e-Registry (PriMePain)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/45870
• EU PAS number:
  EUPAS45869
• Study ID:
  45870
• Official title and acronym:
  Retrosepctive Analysis of the efficacy and tolerability of pridinol in patients with muscle pain - an analysis of open-label real-world data provided by the German Pain e-Registry (PriMePain)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Cross-sectional retrospective analysis of anonymized real-world data provided by the German Pain e-Registry on the effectiveness, safety and tolerability of oral pridinol given as add-on treatment in patients with muscle pain (MP) in routine clinical practice.
• Study status:
  Finalised

Research institutions and networks

Institutions

O.Meany-MDPM

Study timelines

Date when funding contract was signed

Planned: 30/11/2020

Actual: 19/01/2021

Study start date

Planned: 01/01/2021

Actual: 25/01/2021

Data analysis start date

Planned: 14/01/2021

Actual: 01/02/2021

Date of final study report

Planned: 31/03/2021

Actual: 29/04/2021

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

Strathmann GmbH & Co KG, O.Meany-MDPM GmbH

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable